nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—GABRQ—attention deficit hyperactivity disorder	0.799	1	CbGaD
Triazolam—GABRQ—forebrain—attention deficit hyperactivity disorder	0.00225	0.0317	CbGeAlD
Triazolam—GABRR1—forebrain—attention deficit hyperactivity disorder	0.00188	0.0265	CbGeAlD
Triazolam—GABRD—forebrain—attention deficit hyperactivity disorder	0.00163	0.023	CbGeAlD
Triazolam—GABRG1—forebrain—attention deficit hyperactivity disorder	0.00157	0.0222	CbGeAlD
Triazolam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.00151	0.0214	CbGeAlD
Triazolam—GABRA4—forebrain—attention deficit hyperactivity disorder	0.00137	0.0194	CbGeAlD
Triazolam—GABRQ—nervous system—attention deficit hyperactivity disorder	0.00122	0.0172	CbGeAlD
Triazolam—GABRR3—nervous system—attention deficit hyperactivity disorder	0.00122	0.0172	CbGeAlD
Triazolam—GABRQ—central nervous system—attention deficit hyperactivity disorder	0.00118	0.0166	CbGeAlD
Triazolam—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00115	0.0162	CbGeAlD
Triazolam—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00115	0.0162	CbGeAlD
Triazolam—GABRD—midbrain—attention deficit hyperactivity disorder	0.00108	0.0152	CbGeAlD
Triazolam—GABRG3—nervous system—attention deficit hyperactivity disorder	0.00107	0.0151	CbGeAlD
Triazolam—GABRR2—nervous system—attention deficit hyperactivity disorder	0.00106	0.0149	CbGeAlD
Triazolam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00105	0.0148	CbGeAlD
Triazolam—GABRG1—midbrain—attention deficit hyperactivity disorder	0.00104	0.0146	CbGeAlD
Triazolam—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.00103	0.0145	CbGeAlD
Triazolam—GABRR1—nervous system—attention deficit hyperactivity disorder	0.00102	0.0144	CbGeAlD
Triazolam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00101	0.0143	CbGeAlD
Triazolam—GABRB1—midbrain—attention deficit hyperactivity disorder	0.00101	0.0142	CbGeAlD
Triazolam—GABRR2—cerebellum—attention deficit hyperactivity disorder	0.000996	0.0141	CbGeAlD
Triazolam—GABRR1—central nervous system—attention deficit hyperactivity disorder	0.000981	0.0138	CbGeAlD
Triazolam—TSPO—forebrain—attention deficit hyperactivity disorder	0.000972	0.0137	CbGeAlD
Triazolam—GABRQ—brain—attention deficit hyperactivity disorder	0.000933	0.0132	CbGeAlD
Triazolam—Halazepam—GABRQ—attention deficit hyperactivity disorder	0.000927	0.165	CrCbGaD
Triazolam—GABRD—nervous system—attention deficit hyperactivity disorder	0.000886	0.0125	CbGeAlD
Triazolam—GABRB3—forebrain—attention deficit hyperactivity disorder	0.000883	0.0125	CbGeAlD
Triazolam—GABRD—central nervous system—attention deficit hyperactivity disorder	0.000853	0.012	CbGeAlD
Triazolam—GABRG1—nervous system—attention deficit hyperactivity disorder	0.000853	0.012	CbGeAlD
Triazolam—GABRA6—nervous system—attention deficit hyperactivity disorder	0.000848	0.012	CbGeAlD
Triazolam—GABRD—cerebellum—attention deficit hyperactivity disorder	0.000833	0.0118	CbGeAlD
Triazolam—GABRB1—nervous system—attention deficit hyperactivity disorder	0.000827	0.0117	CbGeAlD
Triazolam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.000822	0.0116	CbGeAlD
Triazolam—TSPO—cardiovascular system—attention deficit hyperactivity disorder	0.000822	0.0116	CbGeAlD
Triazolam—GABRG1—central nervous system—attention deficit hyperactivity disorder	0.000821	0.0116	CbGeAlD
Triazolam—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.000819	0.146	CrCbGaD
Triazolam—GABRG3—brain—attention deficit hyperactivity disorder	0.000818	0.0115	CbGeAlD
Triazolam—GABRA6—central nervous system—attention deficit hyperactivity disorder	0.000816	0.0115	CbGeAlD
Triazolam—GABRG1—cerebellum—attention deficit hyperactivity disorder	0.000802	0.0113	CbGeAlD
Triazolam—GABRA6—cerebellum—attention deficit hyperactivity disorder	0.000798	0.0113	CbGeAlD
Triazolam—GABRB1—central nervous system—attention deficit hyperactivity disorder	0.000796	0.0112	CbGeAlD
Triazolam—Oxazepam—GABRQ—attention deficit hyperactivity disorder	0.000793	0.141	CrCbGaD
Triazolam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.000792	0.0112	CbGeAlD
Triazolam—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.000783	0.14	CrCbGaD
Triazolam—GABRR1—brain—attention deficit hyperactivity disorder	0.000779	0.011	CbGeAlD
Triazolam—GABRB1—cerebellum—attention deficit hyperactivity disorder	0.000778	0.011	CbGeAlD
Triazolam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.000765	0.0108	CbGeAlD
Triazolam—GABRB2—midbrain—attention deficit hyperactivity disorder	0.000759	0.0107	CbGeAlD
Triazolam—GABRG2—midbrain—attention deficit hyperactivity disorder	0.000759	0.0107	CbGeAlD
Triazolam—Midazolam—GABRQ—attention deficit hyperactivity disorder	0.000759	0.135	CrCbGaD
Triazolam—GABRA4—nervous system—attention deficit hyperactivity disorder	0.000746	0.0105	CbGeAlD
Triazolam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.000737	0.0104	CbGeAlD
Triazolam—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.000718	0.0101	CbGeAlD
Triazolam—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.000702	0.00991	CbGeAlD
Triazolam—GABRD—brain—attention deficit hyperactivity disorder	0.000677	0.00955	CbGeAlD
Triazolam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00067	0.00946	CbGeAlD
Triazolam—GABRG1—brain—attention deficit hyperactivity disorder	0.000652	0.0092	CbGeAlD
Triazolam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.00065	0.116	CrCbGaD
Triazolam—GABRA6—brain—attention deficit hyperactivity disorder	0.000648	0.00914	CbGeAlD
Triazolam—TSPO—midbrain—attention deficit hyperactivity disorder	0.000642	0.00906	CbGeAlD
Triazolam—GABRB1—brain—attention deficit hyperactivity disorder	0.000632	0.00892	CbGeAlD
Triazolam—GABRA5—brain—attention deficit hyperactivity disorder	0.000629	0.00887	CbGeAlD
Triazolam—GABRB2—nervous system—attention deficit hyperactivity disorder	0.000624	0.00881	CbGeAlD
Triazolam—GABRG2—nervous system—attention deficit hyperactivity disorder	0.000624	0.00881	CbGeAlD
Triazolam—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.000601	0.00848	CbGeAlD
Triazolam—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.000601	0.00848	CbGeAlD
Triazolam—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.000587	0.00829	CbGeAlD
Triazolam—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.000587	0.00829	CbGeAlD
Triazolam—GABRA3—brain—attention deficit hyperactivity disorder	0.000585	0.00826	CbGeAlD
Triazolam—GABRB3—midbrain—attention deficit hyperactivity disorder	0.000583	0.00823	CbGeAlD
Triazolam—GABRA4—brain—attention deficit hyperactivity disorder	0.00057	0.00805	CbGeAlD
Triazolam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00057	0.00805	CbGeAlD
Triazolam—GABRE—nervous system—attention deficit hyperactivity disorder	0.000565	0.00798	CbGeAlD
Triazolam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.000551	0.00778	CbGeAlD
Triazolam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.000549	0.00775	CbGeAlD
Triazolam—GABRE—central nervous system—attention deficit hyperactivity disorder	0.000544	0.00768	CbGeAlD
Triazolam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.000536	0.00757	CbGeAlD
Triazolam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00053	0.00749	CbGeAlD
Triazolam—TSPO—nervous system—attention deficit hyperactivity disorder	0.000528	0.00745	CbGeAlD
Triazolam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.000518	0.00732	CbGeAlD
Triazolam—TSPO—central nervous system—attention deficit hyperactivity disorder	0.000508	0.00717	CbGeAlD
Triazolam—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000501	0.00707	CbGeAlD
Triazolam—TSPO—cerebellum—attention deficit hyperactivity disorder	0.000497	0.00701	CbGeAlD
Triazolam—GABRB3—nervous system—attention deficit hyperactivity disorder	0.000479	0.00676	CbGeAlD
Triazolam—GABRB2—brain—attention deficit hyperactivity disorder	0.000477	0.00673	CbGeAlD
Triazolam—GABRG2—brain—attention deficit hyperactivity disorder	0.000477	0.00673	CbGeAlD
Triazolam—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.000461	0.00651	CbGeAlD
Triazolam—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.000451	0.00636	CbGeAlD
Triazolam—GABRA2—brain—attention deficit hyperactivity disorder	0.000436	0.00615	CbGeAlD
Triazolam—GABRE—brain—attention deficit hyperactivity disorder	0.000432	0.0061	CbGeAlD
Triazolam—GABRA1—brain—attention deficit hyperactivity disorder	0.000421	0.00594	CbGeAlD
Triazolam—TSPO—brain—attention deficit hyperactivity disorder	0.000403	0.00569	CbGeAlD
Triazolam—GABRB3—brain—attention deficit hyperactivity disorder	0.000366	0.00517	CbGeAlD
Triazolam—CYP2C8—brain—attention deficit hyperactivity disorder	0.000277	0.00391	CbGeAlD
Triazolam—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.000274	0.0488	CrCbGaD
Triazolam—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000269	0.0479	CrCbGaD
Triazolam—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000245	0.00346	CbGeAlD
Triazolam—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000236	0.00333	CbGeAlD
Triazolam—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	0.000189	0.0338	CrCbGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000152	0.00122	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000152	0.00122	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000152	0.00122	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000151	0.00121	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000151	0.00121	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00015	0.0012	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000149	0.00119	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000149	0.00119	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000149	0.00119	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000148	0.00119	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000148	0.00118	CbGpPWpGaD
Triazolam—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	0.000146	0.0261	CrCbGaD
Triazolam—GABRB1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000146	0.00117	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000145	0.00116	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000144	0.00115	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000144	0.00115	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000144	0.00115	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000143	0.00115	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000142	0.00114	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000142	0.00114	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000142	0.00114	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000141	0.00113	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000141	0.00113	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00014	0.00112	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000138	0.00111	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000138	0.0011	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000137	0.0011	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000136	0.00109	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000136	0.00109	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000136	0.00109	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000136	0.00109	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000134	0.00108	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000133	0.00107	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000133	0.00107	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000131	0.00105	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000131	0.00105	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000131	0.00105	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00013	0.00104	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00013	0.00104	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00013	0.00104	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000129	0.00103	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000128	0.00103	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000128	0.00103	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000128	0.00103	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000128	0.00102	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000128	0.00102	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000127	0.00102	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000127	0.00102	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000127	0.00102	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000127	0.00102	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000127	0.00101	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000126	0.00101	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000125	0.001	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000125	0.001	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000125	0.001	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000125	0.000998	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000124	0.000993	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000123	0.000983	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000122	0.000976	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000122	0.000976	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000121	0.00097	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000121	0.000969	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00012	0.000959	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000119	0.000952	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000119	0.000952	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000119	0.00095	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000118	0.000948	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000117	0.000938	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000117	0.000937	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000117	0.000936	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000117	0.000934	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000116	0.000931	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000116	0.000929	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000116	0.000928	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000115	0.000923	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000114	0.000917	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000114	0.000916	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000114	0.000914	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000114	0.000913	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000113	0.000908	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000113	0.000902	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000112	0.000895	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000111	0.000885	CbGpPWpGaD
Triazolam—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00011	0.000884	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00011	0.000883	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00011	0.000878	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000109	0.000874	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000109	0.000872	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000109	0.000872	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000109	0.000872	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000109	0.00087	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000108	0.000868	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000108	0.000866	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000108	0.000866	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000108	0.000864	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000108	0.000863	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000107	0.000858	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000107	0.000857	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000106	0.000849	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000105	0.000845	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000105	0.000838	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000104	0.000834	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000104	0.000832	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000104	0.000832	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000102	0.000819	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0001	0.000805	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.98e-05	0.000799	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	9.96e-05	0.000798	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.96e-05	0.000798	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.85e-05	0.000789	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.83e-05	0.000787	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.8e-05	0.000785	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.78e-05	0.000784	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.71e-05	0.000777	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.68e-05	0.000775	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.57e-05	0.000767	CbGpPWpGaD
Triazolam—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	9.56e-05	0.000766	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	9.54e-05	0.000764	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.5e-05	0.000761	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.5e-05	0.000761	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.4e-05	0.000753	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.34e-05	0.000748	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.33e-05	0.000747	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.28e-05	0.000743	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	9.26e-05	0.000742	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.24e-05	0.00074	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	9.21e-05	0.000737	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.18e-05	0.000735	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.17e-05	0.000735	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.11e-05	0.00073	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.11e-05	0.00073	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.01e-05	0.000722	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	8.97e-05	0.000718	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	8.95e-05	0.000717	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.91e-05	0.000713	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.88e-05	0.000711	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—COMT—attention deficit hyperactivity disorder	8.83e-05	0.000708	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.77e-05	0.000703	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.63e-05	0.000691	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	8.57e-05	0.000686	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.47e-05	0.000678	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—COMT—attention deficit hyperactivity disorder	8.36e-05	0.000669	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.32e-05	0.000667	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.3e-05	0.000665	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.27e-05	0.000662	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	8.25e-05	0.000661	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.2e-05	0.000656	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	8.17e-05	0.000654	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.12e-05	0.00065	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	8.11e-05	0.00065	CbGpPWpGaD
Triazolam—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	8.06e-05	0.000645	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	7.96e-05	0.000638	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	7.88e-05	0.000631	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	7.82e-05	0.000626	CbGpPWpGaD
Triazolam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	7.78e-05	0.000623	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	7.78e-05	0.000623	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	7.55e-05	0.000605	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.5e-05	0.0006	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	7.33e-05	0.000587	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.28e-05	0.000583	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.22e-05	0.000578	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	7.2e-05	0.000577	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.15e-05	0.000573	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	7.1e-05	0.000568	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	7.08e-05	0.000567	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	7.03e-05	0.000563	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.03e-05	0.000563	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.98e-05	0.000559	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	6.9e-05	0.000553	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.89e-05	0.000552	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.89e-05	0.000552	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.86e-05	0.000549	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	6.04e-05	0.000483	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	5.99e-05	0.00048	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.91e-05	0.000473	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.87e-05	0.00047	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.83e-05	0.000467	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.67e-05	0.000454	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.59e-05	0.000447	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.29e-05	0.000423	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.22e-05	0.000418	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	5.13e-05	0.000411	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.12e-05	0.00041	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.08e-05	0.000407	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.05e-05	0.000404	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.77e-05	0.000382	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.64e-05	0.000371	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.55e-05	0.000365	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.48e-05	0.000358	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.45e-05	0.000356	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.37e-05	0.00035	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.16e-05	0.000333	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.13e-05	0.000331	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.12e-05	0.00033	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.11e-05	0.000329	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.82e-05	0.000306	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.34e-05	0.000268	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.75e-05	0.00022	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.73e-05	0.000218	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.71e-05	0.000217	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.42e-05	0.000193	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.31e-05	0.000185	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	2.31e-05	0.000185	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	2.27e-05	0.000182	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.11e-05	0.000169	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.09e-05	0.000168	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.84e-05	0.000148	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.76e-05	0.000141	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.7e-05	0.000136	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	1.67e-05	0.000134	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.67e-05	0.000134	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	1.64e-05	0.000131	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.53e-05	0.000122	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	1.44e-05	0.000116	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.44e-05	0.000116	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	1.42e-05	0.000114	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	1.4e-05	0.000112	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	1.39e-05	0.000111	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.33e-05	0.000107	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.32e-05	0.000106	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.27e-05	0.000102	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	1.18e-05	9.41e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.18e-05	9.41e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.16e-05	9.26e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.15e-05	9.25e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.12e-05	8.99e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.1e-05	8.8e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.08e-05	8.61e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	1.01e-05	8.09e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	1e-05	8.03e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.4e-06	7.53e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.95e-06	7.16e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	8.75e-06	7.01e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	8.69e-06	6.96e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.43e-06	6.75e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.75e-06	6.21e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.75e-06	6.21e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.63e-06	6.11e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	7.12e-06	5.7e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.09e-06	5.68e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	7.07e-06	5.66e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.86e-06	5.49e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.2e-06	4.96e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	5.99e-06	4.8e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.9e-06	4.72e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.7e-06	3.76e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.66e-06	3.73e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	4.33e-06	3.47e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	3.75e-06	3.01e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	3.05e-06	2.45e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.01e-06	1.61e-05	CbGpPWpGaD
